Division of Cardiovascular Thoracic Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Division of Cardiovascular Thoracic Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Ann Thorac Surg. 2013 Oct;96(4):1413-1419. doi: 10.1016/j.athoracsur.2013.05.087. Epub 2013 Aug 27.
Patients with failing Fontan circulation are at high risk for complications after heart transplantation (HTx) because of multiple prior operations, elevated panel reactive antibody, hepatic dysfunction, coagulopathy, protein-losing enteropathy (PLE), and poor nutrition. The purpose of this review was to evaluate the outcome of HTx for these patients, including those who are status post-Fontan conversion.
Of 206 heart transplants at Ann & Robert H. Lurie Children's Hospital of Chicago from 1990 to 2012, 22 patients had a failing Fontan. Median age at HTx was 12.2 years, median interval from initial Fontan to HTx was 7.1 years. Potential preoperative risk factors included PLE (n = 15), mechanical ventilation (n = 8), prior Fontan conversion (n = 7), renal failure (n = 3), and plastic bronchitis (n = 2) Median number of prior operations was 3. Donor branch pulmonary arteries were used in 17 patients.
There were 5 early deaths (23%), due to graft failure (1), pulmonary hypertension (1), and infection (3). There were 3 late deaths (13%) at 1, 5, and 8 years. Two of 3 patients with preoperative renal failure died. Survivors who had preoperative PLE (n = 11) and preoperative plastic bronchitis (n = 2) experienced complete resolution of these pathological conditions after heart transplantation. Median length of stay was 30 days. Five of 7 Fontan conversion patients survived, and 6 of 8 preoperative ventilator-dependent patients survived. One-, 5-, and 10-year survival was 77%, 66%, and 45%, respectively.
The operative mortality of HTx for patients with a failing Fontan is high. Using the donor branch pulmonary arteries greatly facilitated the transplant. Because infection caused the majority of early deaths, lower intensity initial immunosuppression may be warranted. Transplantation was successful in treating PLE in all survivors. Prior Fontan conversion was not a risk factor. Preoperative mechanical ventilation was not a risk factor. Preoperative renal failure may be a relative contraindication. Earlier referral of failing Fontan patients may improve results.
由于多次先前的手术、升高的面板反应性抗体、肝功能障碍、凝血功能障碍、蛋白丢失性肠病(PLE)和营养不良,患有失败的 Fontan 循环的患者在心脏移植(HTx)后存在高并发症风险。本研究的目的是评估这些患者(包括那些经历过 Fontan 转换的患者)进行 HTx 的结果。
在 1990 年至 2012 年期间,芝加哥安与罗伯特·H·卢里儿童医院进行了 206 例心脏移植,其中 22 例患者存在失败的 Fontan。HTx 时的中位年龄为 12.2 岁,从初始 Fontan 到 HTx 的中位间隔为 7.1 年。潜在的术前危险因素包括 PLE(n=15)、机械通气(n=8)、先前的 Fontan 转换(n=7)、肾功能衰竭(n=3)和塑料性支气管炎(n=2)。中位手术次数为 3 次。17 例患者使用供体肺动脉。
5 例患者(23%)早期死亡,分别由移植物衰竭(1 例)、肺动脉高压(1 例)和感染(3 例)引起。3 例患者(13%)在术后 1、5 和 8 年死亡。2 例术前肾功能衰竭患者死亡。术前存在 PLE(n=11)和术前塑料性支气管炎(n=2)的幸存者在心脏移植后这些病理情况完全缓解。中位住院时间为 30 天。7 例 Fontan 转换患者中有 5 例存活,8 例术前依赖呼吸机的患者中有 6 例存活。1、5 和 10 年生存率分别为 77%、66%和 45%。
对于存在失败的 Fontan 循环的患者,HTx 的手术死亡率较高。使用供体肺动脉极大地促进了移植。由于感染导致大多数早期死亡,可能需要降低初始免疫抑制强度。所有幸存者的 PLE 均通过移植得到成功治疗。先前的 Fontan 转换不是危险因素。术前机械通气不是危险因素。术前肾功能衰竭可能是相对禁忌证。更早地转介失败的 Fontan 患者可能会改善结果。